Siemens Molecular Imaging, Biomarker Research, Culver City, California 90230, USA.
J Nucl Med. 2010 Feb;51(2):282-7. doi: 10.2967/jnumed.109.065946.
An integrated elastomeric microfluidic device, with a footprint the size of a postage stamp, has been designed and optimized for multistep radiosynthesis of PET tracers.
The unique architecture of the device is centered around a 5-microL coin-shaped reactor, which yields reaction efficiency and speed from a combination of high reagent concentration, pressurized reactions, and rapid heat and mass transfer. Its novel features facilitate mixing, solvent exchange, and product collection. New mixing mechanisms assisted by vacuum, pressure, and chemical reactions are exploited.
The architecture of the reported reactor is the first that has allowed batch-mode microfluidic devices to produce radiopharmaceuticals of sufficient quality and quantity to be validated by in vivo imaging.
The reactor has the potential to produce multiple human doses of (18)F-FDG; the most impact, however, is expected in the synthesis of PET radiopharmaceuticals that can be made only with low yields by currently available equipment.
一种集成的弹性体微流控器件,其占地面积与邮票大小相当,已被设计和优化用于多步正电子发射断层扫描 (PET) 示踪剂的放射性合成。
该器件的独特结构围绕着一个 5 μL 的硬币形反应器,通过高试剂浓度、加压反应以及快速的热和质量传递的结合,实现了反应效率和速度的提高。其新颖的特点便于混合、溶剂交换和产物收集。利用真空、压力和化学反应辅助的新混合机制。
所报道的反应器的结构是第一个允许批处理模式微流控设备生产足够质量和数量的放射性药物,以便通过体内成像进行验证的结构。
该反应器有可能生产出多个人剂量的 (18)F-FDG;然而,预计影响最大的是目前可用设备只能以低产率合成的 PET 放射性药物的合成。